Table 4.
Prevalence in cohort (%) |
Prevalence in decedents (%) |
RRa (95% CI) a |
PAR (%)b (95% CI) |
|
---|---|---|---|---|
All women (N=6,382; 450 deaths) | ||||
Low total PA | 33.3 | 57.6 | 1.69 (1.38, 2.01) | 23.5 (14.3, 31.8) |
Current smoker | 2.6 | 3.1 | 1.72 (1.01, 2.95) | 1.3 (−0.4, 2.9) |
≥1 comorbidity | 83.1 | 92.0 | 1.48 (1.05, 2.09) | 29.8 (3.4, 49.0) |
Low physical function (SPPB <5) | 9.0 | 23.4 | 1.62 (1.26, 2.09) | 9.0 (3.6, 13.9) |
Women ≥80 years (N=3,171; 360 deaths) | ||||
Low total PA | 41.7 | 59.7 | 1.64 (1.31, 2.06) | 23.3 (12.4, 32.9) |
Current smoker | 1.5 | 2.2 | 1.80 (0.89, 3.65) | 1.0 (−0.6, 2.5) |
≥1 comorbidity | 86.9 | 91.7 | 1.30 (0.89, 1.91) | 21.2 (−11.8, 44.4) |
Low physical function (SPPB <5) | 14.4 | 25.1 | 1.53 (1.17, 2.00) | 8.7 (2.4, 14.6) |
Adjusted for awake accelerometer wear-time, age, race-ethnicity, education, alcohol, age at menopause, self-rated general health and the other characteristics in the table.
Calculated using the following formula22: Pc(1−1/RRadj), where Pc is the prevalence of a risk factor among decedents and RRadj is the multivariable adjusteda relative risk for mortality associated with the specified risk factor.